Press Releases :: NeoGenomics, Inc. (NEO)

NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types

NeoGenomics to Participate in Upcoming Investor Conferences

Menu

Test Search

Year

Category

Sep 23, 2015 7:00 am EDT

NeoGenomics Launches New NeoSITE™ Cervical FISH Assay for Evaluation of Abnormal Pap Tests

Sep 2, 2015 7:00 am EDT

NeoGenomics Enters into National Agreement with Premier, Inc. to Offer Cancer Genetics Testing Services to 3,600 Hospitals

Jul 23, 2015 7:00 am EDT

NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA

Jul 22, 2015 7:00 am EDT

NeoGenomics Expands Multimodality Cancer Profile Testing

Jul 20, 2015 7:00 am EDT

NeoGenomics Launches Germline Cancer Predisposition Testing

Jun 30, 2015 2:45 pm EDT

NeoGenomics Schedules its Q2 2015 Earnings Release for July 23, 2015

Jun 17, 2015 7:00 am EDT

NeoGenomics Announces New Directors

Jun 16, 2015 7:00 am EDT

NeoGenomics Set to Join Russell 3000 Index

Jun 11, 2015 7:00 am EDT

NeoGenomics Launches Twelve NeoLAB™ "Liquid Biopsy" Tests for Hematologic Diseases

Apr 28, 2015 7:00 am EDT

NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition